New Huberman Lab podcast out now: THE SCIENCE OF HUNGER & MEDICATIONS TO COMBAT OBESITY with Dr Zachary Knight of @ucsfmedicine - In the new episode of the Huberman Lab podcast out now, my guest is Dr. Zachary Knight, Ph.D., a professor of physiology at the University of California, San Francisco (UCSF), and Howard Hughes Medical Institute (HHMI) investigator. - We discuss how the brain controls our sense of hunger, satiety, and thirst. He explains how dopamine levels impact our cravings and eating behavior (amount, food choices, etc) and how we develop and can change our food preferences and adjust how much we need to eat to feel satisfied. - We discuss factors that have led to the recent rise in obesity, such as interactions between our genes and the environment and the role of processed foods and food combinations. - We also discuss the new class of medications developed for the treatment of obesity and diabetes, including the GLP-1 agonists semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro). We discuss how these work to promote weight loss, the source of their side effects, and the newer compounds soon to overcome some of those side effects, such as muscle loss. - Dr. Knight provides an exceptionally clear explanation for our sense of hunger, thirst, and food cravings that translates to practical knowledge to help listeners better understand their relationship to food, food choices, and meal size to improve their diet and overall health. - You can find the episode in all formats by going to hubermanlab.com. It’s linked there and time-stamped in detail so that you can navigate quickly to the topics most of interest to you. - Meanwhile, put any questions you have in the comments section below this post and as always, thank you for your interest in science! - @hubermanlab @stanford.med @stanford @ucsfmedicine - #neuroscience #science #ciencia #neurociencia #food #hunger #eating #glp1 #glucagon #ozempic